Your browser doesn't support javascript.
loading
Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India.
Mandal, Sucharita; Spoorthy, Mamidipalli Sai; Godi, Sangha Mitra; Nanda, Rachita; Mukherjee, Bhaskar; Mishra, Nihar Ranjan.
Afiliación
  • Mandal S; Psychiatry, All India Institute of Medical Sciences, Kalyani, Kalyani, IND.
  • Spoorthy MS; Psychiatry, All India Institute of Medical Sciences, Bibinagar, Bibinagar, IND.
  • Godi SM; Psychiatry, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
  • Nanda R; Biochemistry, All India Institute of Medical Sciences, Raipur, Raipur, IND.
  • Mukherjee B; Psychiatry, Malda Medical College, Kolkata, IND.
  • Mishra NR; Paediatrics, All India Institute of Medical Sciences, Kalyani, Kalyani, IND.
Cureus ; 15(8): e43059, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37680396
Background Patients with major depressive disorder have varying response rates to treatment. Multiple factors such as non-adherence, comorbidity, chronic stressors, and biological factors may be responsible for this variation. Inflammatory (pro and anti) markers have been well studied as a cause for depression, predisposing factors, and a consequence of depression. Among these, interleukins (ILs), interferons, C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) have been studied repeatedly. We conducted a pilot study to assess the levels of these inflammatory markers in patients with major depressive disorder. The specific objectives of this study were to compare and correlate changes in pro- and anti-inflammatory markers throughout different phases of depression, including pretreatment and posttreatment periods, and to evaluate the pattern of pro- and anti-inflammatory markers in patients who experienced remission or showed a positive response to treatment. Methodology This was a prospective, clinic-based, cohort study done for a period of one and a half years. Patients aged 18-65 years with depressive disorder per the International Classification of Diseases Tenth Edition and who scored more than 7 on the Hamilton Depression Rating Scale were included in this study. A total of 81 patients were recruited who were followed up till eight weeks after inclusion. A total of 31 patients completed the eight weeks of follow-up. Levels of IL-10 and TNF-α were assessed at baseline, two weeks, four weeks, and eight weeks of follow-up. Results This study tried to compare the levels of pro- and anti-inflammatory markers across pretreatment and various posttreatment phases of depression. Results showed that the levels of pro-inflammatory cytokine TNF-α increased from baseline till eight weeks of follow-up, and levels of IL-10 decreased from baseline till eight weeks of follow-up. However, these changes were not statistically significant. Conclusions This study supports the hypothesis that inflammatory markers can be trait markers of depression rather than the consequence or result.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos